CA9 and renal cell carcinoma: In RCC, the use of a single EpCAM antibody has limited enrichment capacity for CTCs; therefore, carbonic anhydrase IX, XII (CAIX, CAXII), and cytokeratin antibodies were used to capture CTCs in conjunction with EpCAM antibodies [24, 25].